Showing results (1-10 of 175) with videos related to
Sort By:
Pageof 18
Experimental Gerontology|July 22, 2008
Aging of the prostate epithelial stem/progenitor cellChristoph Zenzmaier, Gerold Untergasser, Peter BergerThe Prostate|February 6, 2008
Dysregulation of Dkk-3 expression in benign and malignant prostatic tissueChristoph Zenzmaier, Gerold Untergasser, Martin Hermann, et al.Endocrinology|June 18, 2010
Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasiaChristoph Zenzmaier, Natalie Sampson, Dominik Pernkopf, et al.Endocrinology|September 6, 2012
Phosphodiesterase type 5 inhibition reverts prostate fibroblast-to-myofibroblast trans-differentiationChristoph Zenzmaier, Johann Kern, Natalie Sampson, et al.Experimental Gerontology|March 15, 2005
Benign prostatic hyperplasia: age-related tissue-remodelingGerold Untergasser, Stephan Madersbacher, Peter BergerBlood|August 29, 2009
GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomibJohann Kern, Gerold Untergasser, Christoph Zenzmaier, et al.Experimental Gerontology|June 25, 2008
Increase of Dkk-3 blood plasma levels in the elderlyChristoph Zenzmaier, Lilian Sklepos, Peter BergerGerontology|October 27, 2016
The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-ReviewPeter Sandner, Peter Berger, Christoph ZenzmaierBiomed Research International|April 5, 2014
Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic diseaseNatalie Sampson, Peter Berger, Christoph ZenzmaierOxidative Medicine and Cellular Longevity|November 15, 2012
Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic diseaseNatalie Sampson, Peter Berger, Christoph ZenzmaierPageof 18